Inozyme Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Inozyme Pharma and other ETFs, options, and stocks.

About INZY

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton.

CEO

Douglas A. Treco

CEODouglas A. Treco

Employees

Employees67

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2015

Founded2015

Employees

Employees67

INZY Key Statistics

Market cap

63.55M

Market cap63.55M

Price-Earnings ratio

-0.61

Price-Earnings ratio-0.61

Dividend yield

—

Dividend yield—

Average volume

445.56K

Average volume445.56K

High today

$1.00

High today$1.00

Low today

$0.9402

Low today$0.9402

Open price

$0.96

Open price$0.96

Volume

255.96K

Volume255.96K

52 Week high

$6.24

52 Week high$6.24

52 Week low

$0.721

52 Week low$0.721

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

Inozyme Pharma

Why Robinhood?

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. Show more

INZY Key Statistics

Analyst ratings

100%

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton.